スポンサーリンク
Hematology And Stem Cell Transplantation Division National Cancer Center Hospital | 論文
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer : Japan Clinical Oncology Group study, JCOG 9208
- Phase II Study of Cladribine(2-Chlorodeoxyadenosine) in Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma
- Case-control study of leukemia and diagnostic radiation exposure
- Therapy-Related Leukemia and Myelodysplastic Syndrome: A Large-scale Japanese Study of Clinical and Cytogenetic Features as Well as Prognostic Factors
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
- Increased incidence of interstitial pneumonia by CHOP combined with rituximab
- B-cell lymphoma accompanying monoclonal macroglobulinemia with features suggesting marginal zone B-cell lymphoma
- Association between vitamin D and calcium intake and breast cancer risk according to menopausal status and receptor status in Japan
- Heavy smoking history interacts with chemoradiotherapy for esophageal cancer prognosis : A retrospective study
- Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma : Japan Clinical Oncology Group study 9004
- A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients : Japan Clinical Oncology Group Study JCOG9203
- Leukemic infiltration of the lung following allogeneic hematopoietic stem cell transplantation
- Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab
- Primary colorectal T-cell lymphoma
- Phase I Study of the Combination of Irinotecan Hydrochloride, Carbplatin, and Dexamethasone for the Treatment of Relapsed or Refractory Malignanty Lymphoma
- CD44 Variant Isoform Expression and Breast Cancer Prognosis
- Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase